These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2616618)

  • 1. Formulation and evaluation of ibuprofen injections.
    Jain NK; Jahagirdar A
    Pharmazie; 1989 Oct; 44(10):727-8. PubMed ID: 2616618
    [No Abstract]   [Full Text] [Related]  

  • 2. Ibuprofen microcapsules from stearic acid. Part 1: Effect of particle size.
    Kagadis CA; Choulis NH
    Pharmazie; 1985 Nov; 40(11):807-8. PubMed ID: 4095136
    [No Abstract]   [Full Text] [Related]  

  • 3. ["Non-solvent shock agglomeration technology" as a new alternative method for work on ibuprofen. 4. Production and evaluation of quick release forms].
    Möller T; Korsatko W
    Pharmazie; 2000 Jan; 55(1):53-8. PubMed ID: 10683872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analgesic activity following combined oral administration of flupirtine maleate and peripherally acting analgesics in mice and rats.
    Diamantis W; Gordon R; Sofia RD
    Postgrad Med J; 1987; 63 Suppl 3():29-34. PubMed ID: 3447126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ["Non-solvent shock agglomeration"--technology of a new alternative method for sustained release of ibuprofen. 5. Production and evaluation of retard formulations].
    Möller T; Korsatko W
    Pharmazie; 2000 Feb; 55(2):114-9. PubMed ID: 10723769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Behavior of ibuprofen and its formulation in a resorption model].
    Neubert R; Hermann TW; Wieland I; Freesmeyer C
    Pharmazie; 1990 May; 45(5):375-6. PubMed ID: 2395903
    [No Abstract]   [Full Text] [Related]  

  • 7. A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers.
    Li X; Nie SF; Kong J; Li N; Ju CY; Pan WS
    Int J Pharm; 2008 Nov; 363(1-2):177-82. PubMed ID: 18706987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale for ibuprofen co-administration with antacids: potential interaction mechanisms affecting drug absorption.
    Parojcić J; Corrigan OI
    Eur J Pharm Biopharm; 2008 Jun; 69(2):640-7. PubMed ID: 18280125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental research on drug evaluation of ibuprofen oral drop].
    Zhan DZ; Zhu ZG
    Hunan Yi Ke Da Xue Xue Bao; 2002 Jun; 27(3):233-4. PubMed ID: 12575300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions.
    Verma S; Gokhale R; Burgess DJ
    Int J Pharm; 2009 Oct; 380(1-2):216-22. PubMed ID: 19596059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability.
    Mohammed AR; Weston N; Coombes AG; Fitzgerald M; Perrie Y
    Int J Pharm; 2004 Nov; 285(1-2):23-34. PubMed ID: 15488676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microemulsion-based hydrogel formulation of ibuprofen for topical delivery.
    Chen H; Chang X; Du D; Li J; Xu H; Yang X
    Int J Pharm; 2006 Jun; 315(1-2):52-8. PubMed ID: 16600540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment.
    Lamprecht A; Saumet JL; Roux J; Benoit JP
    Int J Pharm; 2004 Jul; 278(2):407-14. PubMed ID: 15196644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation of aqueous injection of carbamazepine.
    Jain NK; Agrawal RK; Singhai AK
    Pharmazie; 1990 Mar; 45(3):221-2. PubMed ID: 2381970
    [No Abstract]   [Full Text] [Related]  

  • 15. Bioavailability of two dermal formulations of S(+)ibuprofen in rabbit.
    González-Peñas E; Echeverría HC; Mosquera J; Esteras A; Bruseghini L
    Arzneimittelforschung; 2003; 53(11):786-92. PubMed ID: 14677375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using cyclodextrin complexation to enhance secondary photoprotection of topically applied ibuprofen.
    Godwin DA; Wiley CJ; Felton LA
    Eur J Pharm Biopharm; 2006 Jan; 62(1):85-93. PubMed ID: 16137872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodegradable ibuprofen-loaded PLGA microspheres for intraarticular administration. Effect of Labrafil addition on release in vitro.
    Fernández-Carballido A; Herrero-Vanrell R; Molina-Martínez IT; Pastoriza P
    Int J Pharm; 2004 Jul; 279(1-2):33-41. PubMed ID: 15234792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of ibuprofen gel formulations using experimental design technique for enhanced transdermal penetration.
    Rhee YS; Chang SY; Park CW; Chi SC; Park ES
    Int J Pharm; 2008 Nov; 364(1):14-20. PubMed ID: 18755258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fast dispersible/slow releasing ibuprofen tablets.
    Fini A; Bergamante V; Ceschel GC; Ronchi C; de Moraes CA
    Eur J Pharm Biopharm; 2008 May; 69(1):335-41. PubMed ID: 18182280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188.
    Newa M; Bhandari KH; Li DX; Kwon TH; Kim JA; Yoo BK; Woo JS; Lyoo WS; Yong CS; Choi HG
    Int J Pharm; 2007 Oct; 343(1-2):228-37. PubMed ID: 17597315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.